Immune response signatures of benzo (α) pyrene exposure in normal human mammary epithelial cells in the absence or presence of chlorophyllin

Cancer Genomics and Proteomics

Volumn 6, Issue 1, 2009, Pages 1-12

  John, Kaarthik ^a,b,c   Keshava, Channa ^b,d   Richardson, Diana L ^b   Weston, Ainsley ^a,b   Nath, Joginder ^a  

^a WEST VIRGINIA UNIVERSITY   (United States)

^b NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

Carcinogens; Chemoprevention; Chlorophyllin; Gene expression; Polycyclic aromatic hydrocarbons

Indexed keywords

BENZO[A]PYRENE; BIOLOGICAL MARKER; CHLOROPHYLL; IMMUNOMODULATING AGENT; POLYCYCLIC AROMATIC HYDROCARBON;

ARTICLE; BREAST EPITHELIUM; CANCER PREVENTION; CARCINOGENICITY; CD86 ANTIGEN GENE; CHEMOKINE CXC LIGAND 14 GENE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DRUG MECHANISM; ENVIRONMENTAL EXPOSURE; FEMALE; GENE; GENE EXPRESSION; GENE INTERACTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNE RESPONSE GENE; IMMUNOMODULATION; INTERFERON ALPHA INDUCIBLE PROTEIN (CLONE IFI 15K) GENE; INTERFERON INDUCED PROTEIN 44 GENE; INTERLEUKIN 1 RECEPTOR ANTAGONIST GENE; INTERLEUKIN 1BETA GENE; MICROARRAY ANALYSIS; MUTATION; NUCLEOTIDE SEQUENCE; ONCOGENE; SECRETED AND TRANSMEMBRANE 1 GENE; UPREGULATION;

EID: 63049113015     PISSN: 11096535     EISSN: 17906245     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. Lawther PJ and Waller RE: Coal fires, industrial emissions and motor vehicles as sources of environmental carcinogens. IARC Sci Publ 13: 27-40, 1976.
2. Miller EC: Some current perspectives on chemical carcinogenesis in humans and experimental animals: Presidential Address 38: 1479-1496, 1978.
3. Sims P and Grover PL: Epoxides in polycyclic aromatic hydrocarbon metabolism and carcinogenesis. Adv Cancer Res 20: 165-274, 1974.
4. Burdick AD, Davis JW, 2nd, Liu KJ, Hudson LG, Shi H, Monske ML and Burchiel SW: Benzo(α)pyrene quinones increase cell proliferation, generate reactive oxygen species, and transactivate the epidermal growth factor receptor in breast epithelial cells. Cancer Res 63: 7825-33, 2003.
5. Parke DV and Sapota A: Chemical toxicity and reactive oxygen species. Int J Occup Med Environ Health 9: 331-340, 1996.
6. Ramesh A, Walker SA, Hood DB, Guillen MD, Schneider K and Weyand EH: Bioavailability and risk assessment of orally ingested polycyclic aromatic hydrocarbons. Int J Toxicol 23: 301-333, 2004.
7. Kadkhoda K, Pourfathollah AA, Pourpak Z and Kazemnejad A: The cumulative activity of benzo(α)pyrene on systemic immune responses with mite allergen extract after intranasal instillation and ex vivo response to ovalbumin in mice. Toxicol Lett 157: 31-39, 2005.
8. Kadkhoda K, Pourpak Z, Akbar Pourfathallah A and Kazemnejad A: The ex vivo study of synergistic effects of polycyclic aromatic hydrocarbon, benzo(α)pyrene with ovalbumin on systemic immune responses by oral route. Toxicology 199: 261-265, 2004.
9. Silkworth JB, Lipinskas T and Stoner CR: Inummosuppressive potential of several polycyclic aromatic hydrocarbons (PAHs) found at a Superfund site: new model used to evaluate additive interactions between benzo[α]pyrene and TCDD. Toxicology 105: 375-386, 1995.
10. 3 particles. Toxicol Lett 121: 107-117, 2001.
11. Laupeze B, Amiot L, Sparfel L, Le Ferrec E, Fauchet R and Fardel O: Polycyclic aromatic hydrocarbons affect functional differentiation and maturation of human monocyte-derived dendritic cells. J Immumol 168: 2652-2658, 2002.
12. Yun CH, Jeong HG, Jhoun JW and Guengerich FP: Non-specific inhibition of cytochrome P450 activities by chlorophyllin in human and rat liver microsomes. Carcinogenesis 16: 1437-1440, 1995.
13. Keshava C, Whipkey D and Weston A: Transcriptional signatures of environmentally relevant exposures in normal human mammary epithelial cells: benzo[α]pyrene. Cancer Lett 221: 201-211, 2005.
14. Stampfer M, Hallowes RC and Hackett AJ: Growth of normal human mammary cells in culture. In Vitro 16: 415-425, 1980.
15. Stampfer MR and Bartley JC: Human mammary epithelial cells in culture: differentiation and transformation. Cancer Treat Res 40: 1-24, 1988.
16. John K, Keshava C, Richardson DL, Weston A and Nath J: Transcriptional profiles of benzo(α)pyrene exposure in normal human mammary epithelial cells in the absence or presence of chlorophyllin. Mutat Res 640: 145-152, 2008.
17. Keshava C, Divi RL, Whilikey DL, Frye BL, McCanlies E, Kuo M, Poirier MC and Weston A: Induction of CYP1A1 and CYPIBI and formation of carcinogen-DNA adducts in normal human mammary epithelial cells treated with benzo[α]pyrene. Cancer Lett 221: 213-224, 2005.
18. John K, Keshava C, Whilikey DL, Weston A and Nath J: Transcritional profiles of normal human mammary epithelial cells exposed to benzo(α)pyrene in the absence or presence of chlorophyllin. Mutat Res, 2008.
19. Affymetrix: Gene chip Expression Analysis: Data Analysis Fundamentals. Affymetrix, Santa Clara, CA, 2002.
20. http://rana.lbl.gov/EisenSoftware.htm.
21. Nikitin A, Egorov S, Daraselia N and Mazo I: Pathway studio--the analysis and navigation of molecular networks. Bioinformatics 19: 2155-2157, 2003.
22. Chung HJ, Kim M, Park CH, Kim J and Kim JH: ArrayXPath: mapping and visualizing microarray gene-expression data with integrated biological pathway resources using Scalable Vector Graphics. Nucleic Acids Res 32: W460-464, 2004.
23. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408, 2001.
24. http://www.cdc.gov/niosh/ext-supp-mat/MTP/index.htm.
25. http://www.cdc.gov/niosh/ext-supp-mat/IR_genes/index.htm.
26. Finn OJ: Human tumor antigens, immunosurveillance, and cancer vaccines. Immunol Res 36: 73-82, 2006.
27. Balogh GA, Russo IH, Spittle C, Heulings R and Russo J: Immune-surveillance and programmed cell death-related genes are significantly overexpressed in the normal breast epithelium of postmenopausal parous women. Int J Oncol 31: 303-312, 2007.
28. Qu M, Muller HK and Woods GM: Chemical carcinogens and antigens contribute to cutaneous tumor promotion by depleting epidermal Langerhans cells. Carcinogenesis 18: 1277-1279, 1997.
29. Rodriguez JW, Kirlin WG, Wirsiy YG, Matheravidathu S, Hodge TW and Urso P: Maternal exposure to benzo[α]pyrene alters development of T lymphocytes in offspring. Immunopharmacol Immunotoxicol 21: 379-396, 1999.
30. Hardin JA, Hinoshita F and Sherr DH: Mechanisms by which benzo[α]pyrene, an environmental carcinogen, suppresses B-cell lymphopoiesis. Toxicol Appl Pharmacol 117: 155-164, 1992.
31. Urso P and Gengozian N: Subnormal expression of cell-mediated and Immoral immune responses in progeny disposed toward a high incidence of tumors after in utero exposure to benzo[α]pyrene. J Toxicol Environ Health 14: 569-584, 1984.
32. Astolfi A, Rolla S, Nanni P, Quaglino E, De Giovanni C, Iezzi M, Musiani P, Fomi G, Lollini PL, Cavallo F and Calogero RA: Immune prevention of mammary carcinogenesis in HER-2/neu transgenic mice: a microarray scenario. Cancer Immunol Immunother 54: 599-610, 2005.
33. Hrelia P, Morotti M, Vigagni F, Maffei F, Paolini M and Forti GC: Murine alpha/beta interferons inhibit benzo(α)pyrene activation and mutagenesis in mice. Basic Life Sci 61: 325-334, 1993.
34. Boloor KK, Kamat JP and Devasagayam TP: Chlorophyllin as a protector of mitochondrial membranes against gamma-radiation and photosensitization. Toxicology 155: 63-71, 2000.
35. Fahey JW, Stephenson KK, Dinkova-Kostova AT, Egner PA, Kensler TW and Talalay P: Chlorophyll, chlorophyllin and related tetrapyrroles are significant inducers of mammalian phase 2 cytoprotective genes. Carcinogenesis 26: 1247-1255, 2005.
36. Chiu LC, Kong CK and Ooi VE: The chlorophyllin-induced cell cycle arrest and apoptosis in human breast cancer MCF-7 cells is associated with ERK deactivation and cyclin D1 depletion. Int J Mol Med 16: 735-740, 2005.
37. Mata JE, Yu Z, Gray JE, Williams DE and Rodriguez-Proteau R: Effects of chlorophyllin on transport of dibenzo(a, 1)pyrene, 2-amino-1-methyl-6-phenylimidazo-[4,5-b]pyridine, and aflatoxin B(1) across Caco-2 cell monolayers. Toxicology 196: 117-125, 2004.
38. Dashwood RH: Chlorophylls as anticarcinogens. Int J Oncol 10, 1997.
39. Sharma D, Kumar SS and Sainis KB: Antiapoptotic and immunomodulatory effects of chlorophyllin. Mol Immunol 44: 347-359, 2007.
40. Ueng TH, Hung CC, Kuo WL, Chan PK, Hu SH, Yang PC and Chang LW: Induction of fibroblast growth factor-9 and interleukin-1alpha gene expression by motorcycle exhaust particulate extracts and benzo(α)pyrene in human lung adenocarcinoma cells. Toxicol Sci 87: 483-496, 2005.
41. Kawaguchi M, Akagi M, Gray MJ, Liu W, Fan F and Ellis LM: Regulation of vascular endothelial growth factor expression in human gastric cancer cells by interleukin-1beta. Surgery 136: 686-692, 2004.
42. Rutter JL, Benbow U, Coon CI and Brinckerhoff CE: Cell-type specific regulation of human interstitial collagenase-1 gene expression by interleukin-1 beta (IL-1 beta) in human fibroblasts and BC-8701 breast cancer cells. J Cell Biochem 66: 322-336, 1997.
43. Lam GK, Liao HX, Xue Y, Alam SM, Scearce RM, Kaufman RE, Sempowski GD and Haynes BF: Expression of the CD7 ligand K-12 in human thymic epithelial cells: regulation by IFN-gamma. J Clin Immunol 25: 41-49, 2005.
44. Matsuda A, Suzuki Y, Honda G, Muramatsu S, Matsuzaki O, Nagano Y, Doi T, Shimotohno K, Harada T, Nishida E, Hayashi H and Sugano S: Large-scale identification and characterization of human genes that activate NF-kappaB and MAPK signaling pathways. Oncogene 22: 3307-3318, 2003.
45. Schwarze SR, Luo J, Isaacs WB and Jarrard DF: Modulation of CXCL14 (BRAK) expression in prostate cancer. Prostate 64: 67-74, 2005.
46. Shellenberger TD, Wang M, Gujrati M, Jayakumar A, Strieter RM, Burdick MD, Ioannides CG, Efferson CL, El-Naggar AK, Roberts D, Clayman GL and Frederick MJ: BRAK/CXCL14 is a potent inhibitor of angiogenesis and a chemotactic factor for immature dendritic cells. Cancer Res 64: 8262-8270, 2004.
47. Allinen M, Beroukhim R, Cai L, Brennan C, Lahti-Domenici J, Huang H, Porter D, Hu M, Chin L, Richardson A, Schnitt S, Sellers WR and Polyak K: Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell 6: 17-32, 2004.
48. Fichtner-Feigl S, Strober W, Kawakami K, Puri RK and Kitani A: IL-13 signaling through the IL-13alpha2 receptor is involved in induction of TGF-beta12 production and fibrosis. Nat Med 12: 99-106, 2006.
49. Gomes FC, Sousa Vde O and Romao L: Emerging roles for TGF-beta1 in nervous system development. Int J Dev Neurosci 23: 413-424, 2005.
50. Huang SS and Huang JS: TGF-beta control of cell proliferation. J Cell Biochem 96: 447-462, 2005.
51. Gorham JD: Transforming growth factor-beta1, Th1 responses, and autoimmune liver disease. Transfusion 45: 51S-59S, 2005.
52. Jeannin P, Magistrelli G, Aubry JP, Caron G, Gauchat JF, Renno T, Herbault N, Goetsch L, Blaecke A, Dietrich PY, Bonnefoy JY and Delneste Y: Soluble CD86 is a co-stimulatory molecule for human T lymphocytes. Immunity 13: 303-312, 2000.
53. Suvas S, Singh V, Sahdev S, Vohra H and Agrewala JN: Distinct role of CD80 and CD86 in the regulation of the activation of B-cell and B-cell lymphoma. J Biol Chem 277: 7766-7775, 2002.
54. Chang X and Han J: Expression of peptidylarginine deiminase type 4 (PAD4) in various tumors. Mol Carcinog 45: 183-196, 2006.
55. Kitamura A, Takahashi K, Okajima A and Kitamura N: Induction of the human gene for p44, a hepatitis-C-associated microtubular aggregate protein, by interferon-alpha/beta. Eur J Biochem 224: 877-83, 1994.
56. Pachiappan A, Thwin MM, Manikandan J and Gopalakrishnakone P: Glial inflammation and neurodegeneration induced by candoxin, a novel neurotoxin from Bungarus candidus venom: global gene expression analysis using microarray. Toxicon 46: 883-899, 2005.
57. Suomela S, Cao L, Bowcock A and Saarialho-Kere U: Interferon alpha-inducible protein 27 (IFI27) is up-regulated in psoriatic skin and certain epithelial cancers. J Invest Dermatol 122: 717-21, 2004.
58. Zhao C, Denison C, Huibregtse JM, Gygi S and Krug RM: Human ISG15 conjugation targets both IFN-induced and constitutively expressed proteins functioning in diverse cellular pathways. Proc Natl Acad Sci USA 102: 10200-10205, 2005.
59. Buanne P, Incerti B, Guardavaccaro D, Avvantaggiato V, Simeone A and Tirone F: Cloning of the human interferon-related developmental regulator (IFRD1) gene coding for the PC4 protein, a member of a novel family of developmentally regulated genes. Genomies 51: 233-242, 1998.
60. Lee CH, Jeon YT, Kim SH and Song YS: NF-kappaB as a potential molecular target for cancer therapy. Biofactors 29: 19-35, 2007.
61. Sarkar FH and Li Y: NF-kappaB: a potential target for cancer chemoprevention and therapy. Front Biosci 13: 2950-2959, 2008.
62. Yun CH, Jeon YJ, Yang Y, Ju HR and Han SH: Chlorophyllin suppresses interleukin-1 beta expression in lipopolysaccharide-activated RAW 264.7 cells. Int Immunopharmacol 6: 252-259, 2006.
63. Yun CH, Son CG, Chung DK and Han SH: Chlorophyllin attenuates IFN-gamma expression in lipopolysaccharide-stimulated murine splenic mononuclear cells via suppressing IL-12 production. Int Immunopharmacol 5: 1926-1935, 2005.